Physician profile
Therese M Lango
NPI 1235136821
$34,062.70
in general payments reported to CMS, 2019-2025
43 companies · $5,012 in 2025
The $5,012 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,497 · 2020: $3,374 · 2021: $5,110 · 2022: $6,628 · 2023: $4,645 · 2024: $6,797 · 2025: $5,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,835 · Travel and Lodging: $7,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,835.00 |
| Travel and Lodging | $7,617.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $19,878.74 | 2019-2025 | Ensite Precision, Aveir, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic, INC. | $3,689.58 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Mycarelink |
| Novartis Pharmaceuticals Corporation | $2,296.87 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,181.26 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $808.80 | 2019-2025 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $769.11 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Amgen INC. | $561.55 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $493.29 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $422.37 | 2022-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $286.46 | 2022-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $286.25 | 2019-2025 | Eliquis, Camzyos |
| Penumbra, INC. | $269.30 | 2024 | Indigo System |
| Shockwave Medical, INC | $266.89 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Irhythm Technologies, INC. | $240.48 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Sanofi-Aventis U.S. LLC | $236.96 | 2019-2024 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $233.45 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| United Therapeutics Corporation | $197.54 | 2019-2025 | Tyvaso, Tyvaso |
| Abiomed | $196.91 | 2025 | |
| Esperion Therapeutics, INC. | $192.09 | 2021-2022 | |
| Amarin Pharma, INC. | $187.53 | 2019-2020 | |
| Boston Scientific Corporation | $170.81 | 2019-2025 | Rotapro |
| Bayer Healthcare Pharmaceuticals INC. | $167.46 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.04 | 2019-2022 | |
| Nuwellis, INC. | $107.30 | 2019-2021 | |
| Preventice Services, LLC | $100.33 | 2020 | |
| Medtronic Vascular, INC. | $87.63 | 2019 | |
| Alnylam Pharmaceuticals INC. | $72.37 | 2025 | Amvuttra |
| Kiniksa Pharmaceuticals International, Plc | $72.26 | 2024 | Arcalyst |
| Medicomp INC | $68.85 | 2023 | Telepatch Cardiac Monitor |
| Edwards Lifesciences Corporation | $52.21 | 2021-2024 | |
| Lexicon Pharmaceuticals, INC. | $34.47 | 2023 | Inpefa |
| Tactile Systems Technology INC | $32.39 | 2020-2023 | Flexitouch Plus, Entre Plus |
| Cardiovascular Systems INC. | $31.88 | 2021-2022 | |
| Baxter Healthcare | $29.00 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Braemar Manufacturing, LLC | $28.09 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $26.78 | 2019 | |
| Lundbeck LLC | $24.11 | 2019 | |
| Chiesi USA, INC. | $23.95 | 2019-2020 | |
| Astellas Pharma US INC | $21.74 | 2019 | |
| Daiichi Sankyo INC. | $18.59 | 2021 | |
| Scpharmaceuticals INC. | $14.84 | 2023 | |
| Philips North America LLC | $14.04 | 2024 | (Cm9) Amb Mon & Diag Und |
| Gilead Sciences, INC. | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Therese Lango listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.